Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 27:13:1238486.
doi: 10.3389/fonc.2023.1238486. eCollection 2023.

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II

Harinder Gill  1 , Nigel Russell  2 , Yok-Lam Kwong  1
Affiliations
Editorial

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II

Harinder Gill et al. Front Oncol. .
No abstract available

Keywords: acute promyelocytic leukemia (APL); arsenic trioxide; chemotherapy-free; early death; epidemiology; oral arsenic trioxide.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II

Similar articles

See all similar articles

References

    1. Jacomo RH, Melo RA, Souto FR, de Mattos ER, de Oliveira CT, Fagundes EM, et al. . Clinical features and outcomes of 134 brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica (2007) 92(10):1431–2. doi: 10.3324/haematol.10874 - DOI - PubMed
    1. Serefhanoglu S, Buyukasik Y, Goker H, Sayinalp N, Haznedaroglu IC, Aksu S, et al. . Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy. Leuk Res (2010) 34(12):e317–9. doi: 10.1016/j.leukres.2010.07.027 - DOI - PubMed
    1. Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, Mollgard L, et al. . Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish adult acute leukemia registry. Leukemia (2011) 25(7):1128–34. doi: 10.1038/leu.2011.78 - DOI - PubMed
    1. Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, et al. . Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood (2011) 118(5):1248–54. doi: 10.1182/blood-2011-04-346437 - DOI - PMC - PubMed
    1. Chen Y, Kantarjian H, Wang H, Cortes J, Ravandi F. Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008. Cancer (2012) 118(23):5811–8. doi: 10.1002/cncr.27623 - DOI - PMC - PubMed

Publication types

LinkOut - more resources